The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury

Journal of Trauma - Injury, Infection and Critical Care

Volumn 59, Issue 3, 2005, Pages 742-746

  Christians, Kathleen ^a,b   Brasel, Karen ^a   Garlitz, James ^b   Abu Hajir, Majed ^a   Gottschall, Jerome ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Surgery ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ABDOMINAL INJURY; ADULT; ARTICLE; BLEEDING; CASE REPORT; CRUSH TRAUMA; FEMALE; HEMATURIA; HUMAN; LABORATORY TEST; MULTIPLE TRAUMA; PELVIS FRACTURE; PRIORITY JOURNAL; RESUSCITATION; TRAFFIC ACCIDENT; URINE CATHETER;

ADULT; BLOOD COAGULATION DISORDERS; FACTOR VIIA; FATAL OUTCOME; FEMALE; HEMORRHAGE; HUMANS; MIDDLE AGED; MULTIPLE TRAUMA; RECOMBINANT PROTEINS; WOUNDS, NONPENETRATING;

EID: 29544443813     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ta.0000197276.55774.c8     Document Type: Article

References (14)

1. Sauaia A, Moore F, Moore E, et al. Epidemiology of trauma deaths; a reassessment. J Trauma. 1995;38:185-193.
2. Gofrit ON, Leibovici D, Shapira S, et al. The trimodal death distribution of trauma victims: Military experience from Lebanon war. Mil Med. 1997;162:24-26.
3. Martinowitz U, Kenet G, Segal E. et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma. 2001;51:431-139.
4. Hedner U. Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment 2000. Semin Thromb Haemost. 2000;26:363-366.
5. White B, McHale J, Ravi N, et al. Successful use of recombinant FVIIa (NovoSeven) in the management of intractable post-surgical intra-abdominal haemorrhage. Br J Haematol. 1999;107:677-678.
6. Martinowitz U. The Use of rFVIIa as an Adjunct Treatment for Hemorrhage Control in Trauma andSurgery. Bloodline Reviews. 2001;1:9-11.
7. Monroe DM, Hoffman M, Allen GA, et al. The factor VII-platelet interplay: effectiveness of the recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Haemost. 2000;26:373-377.
8. O'Neill, P, Bluth M, Gloster E, et al. Successful use of recombinant activated factor VII for trauma-associated hemorrhage in patient without preexisting coagulopathy. J Trauma. 2002;52:400-405.
9. Jurlander B, Thim L, Klausen NK, et al. Recombinant activated factor VII (rFVIIa): Characterization, Manufacturing and Clinical Development. Semin Throm Haemost. 2001;27:373-383.
10. Vlot AJ, Ton E, Mackaay AJ, et al. Treatment of a severely bleeding patient with out preexisting coagulopathy with activated recombinant factor VII. Am J Med. 2000;108:421-123.
11. Al Douri M, Shafi T, Al Khudairi D, et al. Effects of administration of recombinant activated factor VII (rFVIIA; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis. 2000; 11:S121-S127.
12. Friedrich PW, Geerdink MG, Spataro M, et al. The effect of administration of recombinant activated factor VII (NovoSeven) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: The PROSE study. Blood Coagul Fibrinolysis. 2000;11:S129-S132.
13. Roberts UR. Clinical experience with activated factor VII: focus on safety Aspects. Blood Coagul Fibrinolysis. 1998;9: S115-S118.
14. Lynn M. Use of Recombinant Factor VIIA in the Post-Injury Period: A Trauma Surgeon's Perspective. Bloodline Reviews. 2001;1:7-8.